(Q45769835)

parenteral route of administration

17 November 2015

0.1 gram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=B01AD02

medical condition treated

cerebral artery occlusion

1 reference

acute myocardial infarction

2 October 2018

1 reference

2 October 2018

pulmonary embolism

1 reference

2 October 2018

cerebral infarction

1 reference

significant drug interaction

2 October 2018

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fondaparinux

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

Alteplase (English)

17 November 2015

plasminogen activator

1 reference

5 March 2018

0 references

Identifiers

1 reference

Alteplase (English)

17 November 2015

1 reference

Alteplase (English)

19 January 2016

1 reference

Alteplase (English)

17 November 2015

1 reference

Alteplase (English)

17 November 2015

1 reference

26 February 2018

0 references

1 reference

ALTEPLASE (English)

19 January 2016

1 reference

ALTEPLASE (English)

19 January 2016

1 reference

English

title

Alteplase (English)